Elite Health Systems Inc. has reported its financial performance for the fiscal year ending December 31, 2025, revealing a net loss of $7.8 million, a significant increase from the $2.1 million loss recorded in 2024. The company generated $1.0 million in revenue from its subsidiary, Physician Support Systems Inc. (PSS), which it acquired in November 2025. This revenue was derived from leasing employees and providing consulting services to health clinic customers. The cost of revenue for the same period was $906,000, reflecting the expenses associated with these services. The company's selling, general, and administrative expenses surged by 121% to $3.96 million, primarily due to costs related to preparing for its Medicare Advantage plan application in California.
In terms of operational developments, Elite Health began onboarding members for its Medicare Advantage plans in California starting October 2025, following the approval of its Knox-Keene license by the state and the Centers for Medicare & Medicaid Services (CMS). The company is focused on expanding its footprint in the Medicare Advantage market, with plans to introduce specialized Chronic Condition Special Needs Plans (C-SNPs) aimed at beneficiaries with specific chronic conditions. The C-SNP application was filed with CMS in February 2026, targeting conditions such as congestive heart failure and diabetes.
The company’s total assets increased by $2.34 million from 2024 to 2025, largely due to goodwill from the PSS acquisition and investments in software solutions for its Medicare Advantage business. As of December 31, 2025, Elite Health had working capital of $3.14 million, down from $4.16 million the previous year. Cash and cash equivalents stood at $3.76 million, indicating a slight decrease from $4.03 million in 2024. The company has raised approximately $3.7 million through private placements in 2025, which it plans to use to support its Medicare Advantage initiatives.
Looking ahead, Elite Health Systems is optimistic about its growth potential despite the challenges posed by a constrained reimbursement outlook from CMS, which projected a near-flat payment increase of 0.09% for 2027. The company believes that the ongoing expansion of the Medicare Advantage program and the shift towards value-based care reimbursement models will create opportunities for growth. However, the company acknowledges the need for additional capital to support its operations and expansion plans, raising concerns about its ability to continue as a going concern without securing further funding.
Overall, Elite Health Systems is navigating a complex regulatory environment while attempting to establish itself in the competitive Medicare Advantage market. The company is focused on enhancing its operational capabilities and expanding its service offerings to meet the growing healthcare needs of seniors, particularly in California, where it has begun to establish its presence.
About Elite Health Systems Inc.
Elite Health Systems Inc. develops managed care organizations focused on providing Medicare Advantage plans and related health services in California and Nevada. Through its subsidiaries, it aims to establish provider networks, obtain necessary licenses, and deliver community-based, cost-effective healthcare solutions for seniors. The company emphasizes regulatory compliance, provider contracting, and leveraging technology to compete in the highly regulated, low-margin healthcare industry.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.